Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03215472 · ClinicalTrials.gov registry record · NA
DASH Cloud: Using Digital Health to Improve Adherence to the DASH Diet Among Women
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 59
- Enrollment target
NCT03215472: Completed NA study, sponsored by Duke University.
NCT03215472 is a NA study that has completed, run by Duke University. The registered enrollment target is 59 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03215472, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 59 participants
- Enrollment target
Study Summary
This study will test whether a digital health intervention (DASH Cloud) using smartphones can improve diet quality among women at risk for cardiovascular disease. The DASH (Dietary Approaches to Stop Hypertension) Diet has been proven to lower blood pressure, yet dissemination efforts remain poor. This study aims to use technology to improve adherence to DASH.
Primary Outcome
Dietary intake data will be collected using NCI's Automated Self-Administered 24-hour Recall tool.
Interventions
- OTHER DASH Cloud
- OTHER Nutritionix Track app
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59 participants |
| Start Date | 2017-07-21 |
| Est. Completion | 2018-03-12 |
| Phase | NA |
What the finished NCT03215472 record still lists
NCT03215472 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 59 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which DASH Cloud is the first listed.
NCT03215472 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03215472 about?
NCT03215472 is a clinical study titled "DASH Cloud: Using Digital Health to Improve Adherence to the DASH Diet Among Women". This study will test whether a digital health intervention (DASH Cloud) using smartphones can improve diet quality among women at risk for cardiovascular disease. The DASH (Dietary Approaches to Stop Hypertension) Diet has been proven to lower blood pressure, yet dissemination efforts remain poor. T...
What is the current status of trial NCT03215472?
This trial is currently completed. It is a NA study. The enrollment target is 59 participants. The study started on 2017-07-21. Estimated completion is 2018-03-12.
What interventions are being tested in trial NCT03215472?
The interventions under investigation include: DASH Cloud (OTHER), Nutritionix Track app (OTHER).
Who is sponsoring clinical trial NCT03215472?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03215472's enrollment target sits among peer trials
59 1256th of 2000 higher than 745 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03801083 · 59 participants · Phase 2
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Biliary Tract Cancers
- NCT04332367 · 59 participants · Phase 2
Carboplatin, Taxane And Ramucirumab for Patients With NSCLC After Pemetrexed or Pembrolizumab Maintenance
- NCT05489575 · 59 participants · NA
CPAP for the Treatment of Supine Hypertension
- NCT06721689 · 59 participants · Phase 1
PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI